To B or Not to B: Utility of PAX5 in Lineage Assignment of Acute Leukemia

被引：0

作者：

Cedeno, Ernest Hidalgo ^{[1
]}

Germans, Sharon Koorse ^{[2
]}

Pan, Zenggang ^{[3
]}

Weinberg, Olga ^{[2
]}

Xu, Mina ^{[4
]}

机构：

[1] Yale New Haven Hosp, Yale Sch Med, New Haven, CT USA

[2] UT SouthWestern Med Ctr, Dallas, TX USA

[3] Univ Colorado Anschutz Med Campus, Aurora, CO USA

[4] Yale Univ, New Haven, CT USA

来源：

LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1134

引用

页码：S1412 / S1413

页数：2

共 50 条

[41] Pax5 control the B lineage specific gene expression program through association with the nuclear matrix
Hong, Sang Yong
He, Ti
Huang, Lin
Xie, Wanqin
Yu, Zhihong
Su, Kaihong
Zhang, Zhixin
JOURNAL OF IMMUNOLOGY, 2011, 186
[42] EBF restricts alternate lineage options and promotes B cell fate commitment independently of Pax5
Lancki, David William
Pongubala, Jagan M. R.
Northrup, Daniel L.
Medina, Kay L.
Treiber, Thomas
Bertolino, Eric
Thomas, Matthew
Grosschedl, Rudolf
Allman, David
Singh, Harinder
FASEB JOURNAL, 2008, 22
[43] A PAX5 GERMLINE VARIANT IN A PATIENT WITH COMMON VARIABLE IMMUNODEFICIENCY COMPLICATED WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Miyamoto, Satoshi
Koizumi, Miho
Hiroki, Haruka
Nishimura, Akira
Ota, Setsuo
Imai, Kohsuke
Kanegane, Hirokazu
Morio, Tomohiro
Honda, Hiroaki
Takagi, Masatoshi
PEDIATRIC BLOOD & CANCER, 2022, 69
[44] PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Lorenz Bastian
Michael P. Schroeder
Cornelia Eckert
Cornelia Schlee
Jutta Ortiz Tanchez
Sebastian Kämpf
Dimitrios L. Wagner
Veronika Schulze
Konstandina Isaakidis
Juan Lázaro-Navarro
Sonja Hänzelmann
Alva Rani James
Arif Ekici
Thomas Burmeister
Stefan Schwartz
Martin Schrappe
Martin Horstmann
Sebastian Vosberg
Stefan Krebs
Helmut Blum
Jochen Hecht
Philipp A. Greif
Michael A. Rieger
Monika Brüggemann
Nicola Gökbuget
Martin Neumann
Claudia D. Baldus
Leukemia, 2019, 33 : 1895 - 1909
[45] PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Bastian, Lorenz
Schroeder, Michael P.
Eckert, Cornelia
Schlee, Cornelia
Tanchez, Jutta Ortiz
Kaempf, Sebastian
Wagner, Dimitrios L.
Schulze, Veronika
Isaakidis, Konstandina
Lazaro-Navarro, Juan
Haenzelmann, Sonja
James, Alva Rani
Ekici, Arif
Burmeister, Thomas
Schwartz, Stefan
Schrappe, Martin
Horstmann, Martin
Vosberg, Sebastian
Krebs, Stefan
Blum, Helmut
Hecht, Jochen
Greif, Philipp A.
Rieger, Michael A.
Brueggemann, Monika
Goekbuget, Nicola
Neumann, Martin
Baldus, Claudia D.
LEUKEMIA, 2019, 33 (08) : 1895 - 1909
[46] PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia
Zhen Shang
Yuechao Zhao
Kuangguo Zhou
Yanling Xu
Wei Huang
International Journal of Hematology, 2013, 97 : 599 - 603
[47] PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia
Shang, Zhen
Zhao, Yuechao
Zhou, Kuangguo
Xu, Yanling
Huang, Wei
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 599 - 603
[48] Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis
Horcher, M
Souabni, A
Busslinger, M
IMMUNITY, 2001, 14 (06) : 779 - 790
[49] Pax5 isoform expression and mutation status in B-cell chronic lymphocytic leukemia
Arseneau, Jean-Rene
Laflamme, Mark
Ouellette, Rodney
FASEB JOURNAL, 2008, 22
[50] Comparison of PAX5 and CD79a expression in childhood Precursor B Lymphoblastic Leukemia
ALI, Z. A. H. R. A.
MALIK, N. A.
IMRAN, A. Y. I. S. H. A.
CHUGHTAI, A. S.
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (01): : 126 - 128

← 1 2 3 4 5 →